Business · 30/04/1997Updated: 10/17/2026 · 1 min read
FDA Approves New Combination Animal Drug Product Containing Hygromycin B, Pyrantel Tartrate, and Tylosin
Summary
The US Food and Drug Administration (FDA) has approved a new combination animal drug product containing Hygromycin B, Pyrantel Tartrate, and Tylosin, which will be marketed by Zoetis Inc. for the treatment of certain parasitic infections in livestock.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →